InvestorsHub Logo
Followers 44
Posts 16678
Boards Moderated 0
Alias Born 09/16/2012

Re: jobynimble post# 33407

Monday, 05/01/2023 12:26:53 PM

Monday, May 01, 2023 12:26:53 PM

Post# of 34645
Always attacking. Big red flag. But I did read it and it. This is not paying for trials.

"regulatory activity in support"

>>CellReady also agreed to enter into a long-term contract with Marker wherein CellReady will perform a wide variety of services for Marker including research and development, manufacturing, and regulatory activity in support of Marker's clinical trials.

"Restructure"! Reprice options maybe??

>>I look forward to working with the Marker clinical team to advance the development of MT-601 in our ongoing non-Hodgkin's lymphoma trial and eventual pancreatic cancer trial, in addition to MT-401 for our post-transplant AML trail. Additionally, I am spearheading a strategic review process of our clinical programs with the Marker management team as part of our restructuring efforts."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News